SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
522Tuck, Biogen and Elan to present at gastroenterology conference today: Crohn'Harold Engstrom-5/20/2003
521HMMM . . . >>8:47AM Biosite started at Underperform by Wachovia (BSTtuck-5/20/2003
520I remember surfing to some folks commenting on flawed trial design for APPX'tuck-5/19/2003
519off topic on topic..... The annual reports that are rolling in, exclusively BIOscaram(o)uche-5/18/2003
518The answer that you got to your questions, when you first got the Tanox pointer.scaram(o)uche-5/15/2003
517Thanks to those who kept me away from shorting TNOX: >>GAITHERSBURG, Md. tuck-5/15/2003
516Got to give IDBE credit for their timing, but near to intermediate term, this hetuck-5/15/2003
515Tuck >>Thanks for remedying my ignorance a bit. Any competitors for that Icebrg-5/14/2003
514Thanks for remedying my ignorance a bit. Any competitors for that target populatuck-5/14/2003
513I agree regarding the price, but this is at least at the DNA-level a somewhat doIcebrg-5/14/2003
512I grant you price doesn't matter for approval, though it certainly matters ftuck-5/14/2003
511>>And what do folks think of Xolair's (TNOX, DNA) chances for approvalIcebrg-5/14/2003
510>> Anybody fathom why CELG is approaching highs on the day after Velcade aIcebrg-5/14/2003
509And what do folks think of Xolair's (TNOX, DNA) chances for approval, given tuck-5/14/2003
508Anybody fathom why CELG is approaching highs on the day after Velcade approval? tuck-5/14/2003
507De nada. Meanwhile, BSCP shorts the dead cat bounce on QLTI, full position at $tuck-5/13/2003
506Thanks Tuck. I started a bit early today. I have a short that can be added to Techplayer-5/13/2003
505Possibly. PDLI just scrapped IL-4 for asthma following disappointing PII resulttuck-5/13/2003
504Hi Tuck, What do you think of PDLI? It has run about 2 bucks since Thursday onTechplayer-5/13/2003
503BSCP portfolio taking a bit of a hit with this spring rally's unexpected strtuck-5/12/2003
502<i>I can't see their drug 'working' in a short's timeframeBiomaven-5/1/2003
501You're probably right - though somehow I can't see their drug 'workinigel bates-5/1/2003
500<AVII> This is an ultra-high-risk short IMO. All they'd need is anothBiomaven-5/1/2003
499From 1977-2002, some companies publicly or privately challenged short sellers ofrkrw-5/1/2003
498This might slow down AGEN a bit -- geez, they just raised a wad a few months agotuck-4/29/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News